India has approved a 30% trade-margin cap on non-scheduled cancer medicines, with projected annual patient savings of (and) #8377;2,500 crore. Here’s what the decision means.
Cancer Drug Price Cap: Patients Could Save Rs.2,500 Crore
India has approved a 30% trade-margin cap on non-scheduled cancer medicines, with projected annual patient savings of (and) #8377;2,500 crore. Here’s what the decision means.